TOKYO, Apr 01 (Pulse News Wire) – Waqoo Inc. (4937.T) disclosed the non-consolidated financial results of its parent company, SBC Medical Group Kabushiki Kaisha, for the fiscal year ended December 31, 2025.
SBC Medical Group Kabushiki Kaisha, headquartered at Kanagawa, Yokohama Shi Totsuka Ku Kamikuratachou 908, operates in healthcare marketing consulting, pharmaceutical and cosmetic planning, and sales facilitation. As of December 31, 2025, the capital of SBC Medical Group Kabushiki Kaisha stood at ¥12 million. SBC Medical Group Incorporated holds 100.00% of the voting rights. The company's revenue for the fiscal year was 22,172,132 thousand yen, while operating profit reached 10,512,821 thousand yen.
Net profit for the period amounted to 13,824,965 thousand yen. In terms of shareholding, SBC Medical Group Incorporated owns 1,000 shares, representing 100.00% of the outstanding shares. Key officers include Kano Yoshikazu, born on June 09, 1970, who serves as the representative director, and Sakakura Keiko, born on February 11, 1944, serving as a director. As of December 31, 2025, SBC Medical Group Kabushiki Kaisha's balance sheet showed total assets of 49,190,654 thousand yen, with liabilities totaling 9,541,230 thousand yen, resulting in shareholders’ equity of 39,649,424 thousand yen.
The company’s cash and deposits stood at 16,291,158 thousand yen, while long-term borrowings amounted to 3,972,749 thousand yen.
🟡 Confidence: Standard AI-translated content.